Benzinga - U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session.
- Castle Biosciences, Inc. (NASDAQ: CSTL) shares dipped 48% to $11.80. Baird, SVB Securities and Lake Street lowered their price targets on the stock.
- EPAM Systems, Inc. (NASDAQ: EPAM) dropped 17.7% to $213.50 after the company cut its second-quarter financial outlook.
- Amyris, Inc. (NASDAQ: AMRS) fell 16.2% to $0.7885. Amyris initiated strategic transformation program and secured funding to deliver the company's planned cost reduction target of approximately $250 million from cost of goods sold.
- Comtech Telecommunications Corp. (NASDAQ: CMTL) declined 13.7% to $10.64.
- DMC Global Inc. (NASDAQ: BOOM) dropped 13.6% to $15.65.
- SunCar Technology Group Inc. (NASDAQ: SDA) fell 13.2% to $20.22.
- Gannett Co., Inc. (NYSE: GCI) dropped 12.7% to $1.9650.
- Zumiez Inc. (NASDAQ: ZUMZ) fell 11.1% to $13.76. Zumiez recently posted a wider-than-expected quarterly loss.
- IGM Biosciences, Inc. (NASDAQ: IGMS) dipped 10.9% to $12.11. Wedbush reiterated IGM Biosciences with an Outperform and maintained a $37 price target.
- Endava plc (NYSE: DAVA) fell 10.8% to $45.97. Needham reiterated Endava with a Buy and maintained a $68 price target.
- Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) declined 10.6% to $8.77.
- Stitch Fix, Inc. (NASDAQ: SFIX) dropped 10.3% to $3.5250.
- 8x8, Inc. (NASDAQ: EGHT) fell 9.5% to $3.80. 8x8 appointed Samuel Wilson as CEO.
- Metals Acquisition Corp (NASDAQ: MTAL) declined 8.9% to $10.38.
- Cipher Mining Inc. (NASDAQ: CIFR) fell 8.7% to $2.3550.
- Globant SA (NYSE: GLOB) slipped 8.6% to $172.32.
- CPI Card Group Inc. (NASDAQ: PMTS) fell 8% to $25.13. CPI Card Group said President and CEO Scott Scheirman will retire in 2024 effective Feb. 28, 2024.
- Enovix Corporation (NASDAQ: ENVX) dropped 7.7% to $13.16.
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) fell 7.7% to $2.5350.
- Blueprint Medicines Corporation (NASDAQ: BPMC) dipped 6.8% to $54.24. SVB Leerink downgraded Blueprint Medicines from Market Perform to Underperform and lowered the price target from $48 to $43.
- PetMed Express, Inc. (NASDAQ: PETS) dropped 5.5% to $14.79.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Read More: HP, Alphabet And 2 Other Stocks Insiders Are Selling
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.